Planning to initiate or currently receiving neoadjuvant or adjuvant chemotherapy
Expected to continue chemotherapy during the study period and complete at least two treatment time points/cycles
Able and willing to provide informed consent
Able to complete basic smartphone operations and system tasks independently or with guidance from the research staff
You may not be if
Recurrent or metastatic breast cancer (stage IV)
Significant cognitive impairment or communication barriers that preclude informed consent or completion of study procedures
Severe psychiatric disorders or unstable psychiatric symptoms that may interfere with study participation
Considered unsuitable for participation by the clinical or research team because of unstable medical condition or need for acute management
Clareo Health | Development and Usability Evaluation of a Knowledge Graph-Based Symptom Management System for Patients With Breast Cancer Undergoing Chemotherapy
